Catalyst Wire Dossier Catalyst Wire Dossier

Axicabtagene ciloleucel

axicabtagene ciloleucel · Kite, a Gilead Company
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Axicabtagene ciloleucel, covering 2022-07-08 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy [Phase 3]

See pricing